Frontiers in Molecular Medicine

Frontiers Media S.A.

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Frontiers in Molecular Medicine is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Frontiers Media S.A.
ISSN
2674-0095
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,950 CHF
Articles in DOAJ
73
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2022-11-22
Indexing
DOAJ
APC
1,950 CHF
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

73

Most recent article

last month

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

95

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

15

i10-index

28

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-12
Added to DOAJ
2022-11-22
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
93%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918402378306676
Classification2

Subjects (DOAJ)

Medicine: Medicine (General): Computer applications to medicine. Medical informatics

LCC codes

R858-859.7

Subject areas

  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Viral Infectious Diseases and Gene Expression in Insects
Show all subjects (50)
  • Viral Infectious Diseases and Gene Expression in Insects
  • Computational Drug Discovery Methods
  • CRISPR and Genetic Engineering
  • Mitochondrial Function and Pathology
  • Immunotherapy and Immune Responses
  • Neurogenetic and Muscular Disorders Research
  • Computational Drug Discovery Methods
  • Mitochondrial Function and Pathology
  • CRISPR and Genetic Engineering
  • Epigenetics and DNA Methylation
  • Virus-based gene therapy research
  • Bioinformatics and Genomic Networks
  • ATP Synthase and ATPases Research
  • Epigenetics and DNA Methylation
  • Pluripotent Stem Cells Research
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Cell Adhesion Molecules Research
  • Pluripotent Stem Cells Research
  • ATP Synthase and ATPases Research
  • Genetics and Neurodevelopmental Disorders
  • Bioinformatics and Genomic Networks
  • Genetics and Neurodevelopmental Disorders
  • Immune Cell Function and Interaction
  • Cell Adhesion Molecules Research
  • Cancer Immunotherapy and Biomarkers
  • Amyotrophic Lateral Sclerosis Research
  • Amyotrophic Lateral Sclerosis Research
  • SARS-CoV-2 and COVID-19 Research
  • Nanowire Synthesis and Applications
  • Ferroptosis and cancer prognosis
  • Cancer, Hypoxia, and Metabolism
  • SARS-CoV-2 and COVID-19 Research
  • Nanowire Synthesis and Applications
  • Cancer Genomics and Diagnostics
  • Neurogenesis and neuroplasticity mechanisms
  • Cardiac Ischemia and Reperfusion
  • Cancer, Hypoxia, and Metabolism
  • Cancer Genomics and Diagnostics
  • Neurogenesis and neuroplasticity mechanisms
  • Cardiac Ischemia and Reperfusion

Keywords (DOAJ)

  • molecular biology
  • bioinformatics
  • diseases
  • pathology
  • molecular medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: